|Day Low/High||11.26 / 11.88|
|52 Wk Low/High||7.20 / 32.44|
Nivalis Therapeutics, Inc. (NASDAQ: NVLS), a pharmaceutical company historically focused on developing innovative solutions for people with cystic fibrosis (CF), today reported financial results and recent...
Alpine Immune Sciences, a cancer immunotherapy company founded by former Dendreon CEO Mitch Gold, is listing publicly through a merger with Nivalis Therapeutics.
Nivalis Therapeutics, Inc. (NASDAQ: NVLS) and Alpine Immune Sciences, Inc.
Review of Strategic Alternatives Progressing as Operations Streamlined
Here's a technical look at how to trade several under-$10 stocks triggering breakout trades.
Levi & Korsinsky announces it has commenced an investigation of Nivalis Therapeutics, Inc.
Company to Host Conference Call Today, November 28, at 5:00 p.m. EST
Completion of Enrollment in Phase 2 Study of Cavosonstat for Treatment of Cystic Fibrosis Achieved During the Quarter
Here's a technical look at how to trade several under-$10 stocks that were making big moves to the upside recently.
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
Company on track to report results from the study in fourth quarter this year
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.